Patient Guide: A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 12 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05821855
Status: 🟢 Enrolling Now
Condition: Open-angle Glaucoma, OAG
Phase: PHASE4

Where You Can Participate

This study is available at 12 locations across the country.

Top locations include:
  • • Beijing, Beijing Municipality
  • • Beijing, Beijing Municipality
  • • Beijing, Beijing Municipality
  • • And 9 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China - Join Clinical Trial NCTNCT05821855

How to Join This Clinical Trial - NCTNCT05821855

Learn how to participate in this PHASE4 trial studying an investigational therapy for Open-angle Glaucoma, OAG. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Open-angle Glaucoma, OAG. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Open-angle Glaucoma, OAG
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05821855 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 12 locations. Find a study site near you:

Clinical Research Site

Beijing, Beijing Municipality 100044 - China

Status: RECRUITING

Clinical Research Site

Beijing, Beijing Municipality 100191 - China

Status: RECRUITING

Clinical Research Site

Beijing, Beijing Municipality 100730 - China

Status: RECRUITING

Clinical Research Site

Fuzhou, Fujian 350005 - China

Status: RECRUITING

Clinical Research Site

Xiamen, Fujian 390000 - China

Status: COMPLETED

Clinical Research Site

Shenzhen, Guangdong 518034 - China

Status: RECRUITING

Clinical Research Site

Wuhan, Hubei 430030 - China

Status: RECRUITING

Clinical Research Site

Qingdao, Shandong 266071 - China

Status: RECRUITING

Clinical Research Site

Chengdu, Sichuan 610041 - China

Status: RECRUITING

Clinical Research Site

Tianjin, Tianjin Municipality 300070 - China

Status: RECRUITING

And 2 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Open-angle Glaucoma, OAG:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships